Cargando…
Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency
PURPOSE: Primary ovarian insufficiency before the age of 40 years affects 1% of the female population and is characterized by permanent cessation of menstruation. Genetic causes include FMR1 expansion mutations. Previous studies have estimated mutation prevalence in clinical referrals for primary ov...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914024/ https://www.ncbi.nlm.nih.gov/pubmed/23703681 http://dx.doi.org/10.1038/gim.2013.64 |
_version_ | 1782302327283122176 |
---|---|
author | Murray, Anna Schoemaker, Minouk J. Bennett, Claire E. Ennis, Sarah Macpherson, James N. Jones, Michael Morris, Danielle H. Orr, Nick Ashworth, Alan Jacobs, Patricia A. Swerdlow, Anthony J. |
author_facet | Murray, Anna Schoemaker, Minouk J. Bennett, Claire E. Ennis, Sarah Macpherson, James N. Jones, Michael Morris, Danielle H. Orr, Nick Ashworth, Alan Jacobs, Patricia A. Swerdlow, Anthony J. |
author_sort | Murray, Anna |
collection | PubMed |
description | PURPOSE: Primary ovarian insufficiency before the age of 40 years affects 1% of the female population and is characterized by permanent cessation of menstruation. Genetic causes include FMR1 expansion mutations. Previous studies have estimated mutation prevalence in clinical referrals for primary ovarian insufficiency, but these are likely to be biased as compared with cases in the general population. The prevalence of FMR1 expansion mutations in early menopause (between the ages of 40 and 45 years) has not been published. METHODS: We studied FMR1 CGG repeat number in more than 2,000 women from the Breakthrough Generations Study who underwent menopause before the age of 46 years. We determined the prevalence of premutation (55–200 CGG repeats) and intermediate (45–54 CGG repeats) alleles in women with primary ovarian insufficiency (n = 254) and early menopause (n = 1,881). RESULTS: The prevalence of the premutation was 2.0% in primary ovarian insufficiency, 0.7% in early menopause, and 0.4% in controls, corresponding to odds ratios of 5.4 (95% confidence interval = 1.7–17.4; P = 0.004) for primary ovarian insufficiency and 2.0 (95% confidence interval = 0.8–5.1; P = 0.12) for early menopause. Combining primary ovarian insufficiency and early menopause gave an odds ratio of 2.4 (95% confidence interval = 1.02–5.8; P = 0.04). Intermediate alleles were not significant risk factors for either early menopause or primary ovarian insufficiency. CONCLUSION: FMR1 premutations are not as prevalent in women with ovarian insufficiency as previous estimates have suggested, but they still represent a substantial cause of primary ovarian insufficiency and early menopause. |
format | Online Article Text |
id | pubmed-3914024 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-39140242014-02-05 Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency Murray, Anna Schoemaker, Minouk J. Bennett, Claire E. Ennis, Sarah Macpherson, James N. Jones, Michael Morris, Danielle H. Orr, Nick Ashworth, Alan Jacobs, Patricia A. Swerdlow, Anthony J. Genet Med Original Research Article PURPOSE: Primary ovarian insufficiency before the age of 40 years affects 1% of the female population and is characterized by permanent cessation of menstruation. Genetic causes include FMR1 expansion mutations. Previous studies have estimated mutation prevalence in clinical referrals for primary ovarian insufficiency, but these are likely to be biased as compared with cases in the general population. The prevalence of FMR1 expansion mutations in early menopause (between the ages of 40 and 45 years) has not been published. METHODS: We studied FMR1 CGG repeat number in more than 2,000 women from the Breakthrough Generations Study who underwent menopause before the age of 46 years. We determined the prevalence of premutation (55–200 CGG repeats) and intermediate (45–54 CGG repeats) alleles in women with primary ovarian insufficiency (n = 254) and early menopause (n = 1,881). RESULTS: The prevalence of the premutation was 2.0% in primary ovarian insufficiency, 0.7% in early menopause, and 0.4% in controls, corresponding to odds ratios of 5.4 (95% confidence interval = 1.7–17.4; P = 0.004) for primary ovarian insufficiency and 2.0 (95% confidence interval = 0.8–5.1; P = 0.12) for early menopause. Combining primary ovarian insufficiency and early menopause gave an odds ratio of 2.4 (95% confidence interval = 1.02–5.8; P = 0.04). Intermediate alleles were not significant risk factors for either early menopause or primary ovarian insufficiency. CONCLUSION: FMR1 premutations are not as prevalent in women with ovarian insufficiency as previous estimates have suggested, but they still represent a substantial cause of primary ovarian insufficiency and early menopause. Nature Publishing Group 2014-01 2013-05-23 /pmc/articles/PMC3914024/ /pubmed/23703681 http://dx.doi.org/10.1038/gim.2013.64 Text en Copyright © 2014 American College of Medical Genetics and Genomics http://creativecommons.org/licenses/by/3.0/deed.en_US This work is licensed under a Creative Commons Attribution Unported 3.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/deed.en_US |
spellingShingle | Original Research Article Murray, Anna Schoemaker, Minouk J. Bennett, Claire E. Ennis, Sarah Macpherson, James N. Jones, Michael Morris, Danielle H. Orr, Nick Ashworth, Alan Jacobs, Patricia A. Swerdlow, Anthony J. Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency |
title | Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency |
title_full | Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency |
title_fullStr | Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency |
title_full_unstemmed | Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency |
title_short | Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency |
title_sort | population-based estimates of the prevalence of fmr1 expansion mutations in women with early menopause and primary ovarian insufficiency |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914024/ https://www.ncbi.nlm.nih.gov/pubmed/23703681 http://dx.doi.org/10.1038/gim.2013.64 |
work_keys_str_mv | AT murrayanna populationbasedestimatesoftheprevalenceoffmr1expansionmutationsinwomenwithearlymenopauseandprimaryovarianinsufficiency AT schoemakerminoukj populationbasedestimatesoftheprevalenceoffmr1expansionmutationsinwomenwithearlymenopauseandprimaryovarianinsufficiency AT bennettclairee populationbasedestimatesoftheprevalenceoffmr1expansionmutationsinwomenwithearlymenopauseandprimaryovarianinsufficiency AT ennissarah populationbasedestimatesoftheprevalenceoffmr1expansionmutationsinwomenwithearlymenopauseandprimaryovarianinsufficiency AT macphersonjamesn populationbasedestimatesoftheprevalenceoffmr1expansionmutationsinwomenwithearlymenopauseandprimaryovarianinsufficiency AT jonesmichael populationbasedestimatesoftheprevalenceoffmr1expansionmutationsinwomenwithearlymenopauseandprimaryovarianinsufficiency AT morrisdanielleh populationbasedestimatesoftheprevalenceoffmr1expansionmutationsinwomenwithearlymenopauseandprimaryovarianinsufficiency AT orrnick populationbasedestimatesoftheprevalenceoffmr1expansionmutationsinwomenwithearlymenopauseandprimaryovarianinsufficiency AT ashworthalan populationbasedestimatesoftheprevalenceoffmr1expansionmutationsinwomenwithearlymenopauseandprimaryovarianinsufficiency AT jacobspatriciaa populationbasedestimatesoftheprevalenceoffmr1expansionmutationsinwomenwithearlymenopauseandprimaryovarianinsufficiency AT swerdlowanthonyj populationbasedestimatesoftheprevalenceoffmr1expansionmutationsinwomenwithearlymenopauseandprimaryovarianinsufficiency |